United States Immunoglobulin Market Size, Share, and COVID-19 Impact Analysis, By Route of Administration (Intravenous and Subcutaneous), By Indication (Primary Immunodeficiency (PI), Secondary Immunodeficiency (SI), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillian Barre Syndrome, Immune Thrombocytopenic Purpura (ITP), Multifocal Motor Neuropathy (MMN), and Others), By Form (Liquid and Lyophilized), By End User (Hospitals, Clinics, and Homecare), and United States Immunoglobulin Market Insights, Industry Trend, Forecasts to 2033
Premium Report Details
Base Year:
2023
Tables & Figures:
110
Pages:
216
Countries covered:
1
Companies covered::
10
Forecast CAGR:
8.68%
Connect with us
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies